Completely non-invasive prediction of IDH mutation status based on preoperative native CT images
Abstract The isocitrate dehydrogenase (IDH) mutation status is one of the most important markers according to the 2021 WHO classification of CNS tumors. Preoperatively, this information is usually obtained based on invasive biopsies, contrast-enhanced MR images or PET images generated using radioact...
Saved in:
| Main Authors: | Manfred Musigmann, Melike Bilgin, Sabriye Sennur Bilgin, Hermann Krähling, Walter Heindel, Manoj Mannil |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-77789-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IDH mutation, glioma immunogenicity, and therapeutic challenge of primary mismatch repair deficient IDH‐mutant astrocytoma PMMRDIA: a systematic review
by: Olfat Ahmad, et al.
Published: (2024-12-01) -
Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated
by: Malcolm F. McDonald, et al.
Published: (2025-01-01) -
Spectrum of IDH-mutant tumors in Ollier-Maffucci disease: the triple interaction theory
by: Emmanuel Mandonnet, et al.
Published: (2024-11-01) -
VASARI 2.0: a new updated MRI VASARI lexicon to predict grading and IDH status in brain glioma
by: Alberto Negro, et al.
Published: (2024-12-01) -
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
by: Liv Cathrine Heggebø, et al.
Published: (2025-01-01)